{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:33:50Z","timestamp":1754397230195,"version":"3.37.3"},"reference-count":22,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.2217\/fon-2020-0902","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T08:36:23Z","timestamp":1603096583000},"page":"675-688","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Real-World Outcomes Associated with Liposomal Irinotecan Dose Reductions in Metastatic Pancreatic Ductal Adenocarcinoma"],"prefix":"10.1080","volume":"17","author":[{"given":"George P","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Hematology & Oncology,George Washington University, \rWashington \rDC \r20052, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0743-7219","authenticated-orcid":false,"given":"Andy","family":"Surinach","sequence":"additional","affiliation":[{"name":"Genesis Research, \rHoboken, \rNJ \r07030, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank A","family":"Corvino","sequence":"additional","affiliation":[{"name":"Genesis Research, \rHoboken, \rNJ \r07030, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Cockrum","sequence":"additional","affiliation":[{"name":"Ipsen, \rCambridge, \rMA \r02142, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Belanger","sequence":"additional","affiliation":[{"name":"Ipsen, \rCambridge, \rMA \r02142, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laith","family":"Abushahin","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center,The Ohio State University, \rColumbus, \rOH \r43210, \rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21551"},{"key":"e_1_3_3_4_1","unstructured":"American Cancer Society. Cancer statistics center. (2020). https:\/\/cancerstatisticscenter.cancer.org\/?_ga=2.46943649.724153074.1594141117-1538507482.1594141117#!\/"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-0155"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004215"},{"key":"e_1_3_3_7_1","unstructured":"National Cancer Institute (SEER). Surveillance Epidemiology and End Results (SEER) program. Cancer stat facts: pancreatic cancer. National Cancer Institute MD USA. (2020). https:\/\/seer.cancer.gov\/statfacts\/html\/pancreas.html"},{"key":"e_1_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-015-9724-1"},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv295"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2477"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-5714"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1171362"},{"key":"e_1_3_3_13_1","unstructured":"Ispen. Onivyde US PI. (2019). https:\/\/www.ipsen.com\/websites\/Ipsen_Online\/wp-content\/uploads\/sites\/9\/2019\/01\/21083350\/ONIVYDE_USPI.pdf"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4007"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2018.12.007"},{"issue":"8","key":"e_1_3_3_16_1","first-page":"205","article-title":"Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil\/leucovorin (5-FU\/LV): survival analysis from NAPOLI-1","volume":"29","author":"Chen LT","year":"2018","unstructured":"ChenLT, MacarullaTM, BlancJet al.Impact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil\/leucovorin (5-FU\/LV): survival analysis from NAPOLI-1. Ann. Oncol.29(Suppl. 8), 205\u2013270 (2018).","journal-title":"Ann. Oncol."},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4605-1"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919853196"},{"key":"e_1_3_3_19_1","unstructured":"Flatiron Health database. https:\/\/flatiron.com\/real-world-evidence\/"},{"key":"e_1_3_3_20_1","unstructured":"National Center for Health Statistics. Classification of diseases functioning and disability. https:\/\/www.cdc.gov\/nchs\/icd.htm"},{"key":"e_1_3_3_21_1","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000001479"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-019-1309-6"},{"key":"e_1_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758835919871126"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2020-0902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:45Z","timestamp":1719125205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2020-0902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.2217\/fon-2020-0902"],"URL":"https:\/\/doi.org\/10.2217\/fon-2020-0902","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"type":"print","value":"1479-6694"},{"type":"electronic","value":"1744-8301"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-09-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}